ArticleCancer research and treatment2026

Real-World Experience of Weekly Carfilzomib in Combination with Cyclophosphamide and Dexamethasone in Multiple Myeloma Relapsed/Refractory to Bortezomib and Lenalidomide.

Cheongin Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.